| 0 |
OCHRONOSIS |
5 |
0.0704 |
| 1 |
CHLOASMA |
6 |
0.0129 |
| 2 |
DILATED PORES |
1 |
0.0110 |
| 3 |
CHEMICAL INJURY |
8 |
0.0098 |
| 4 |
SKIN HYPOPIGMENTATION |
14 |
0.0079 |
| 5 |
ADMINISTRATION SITE IRRITATION |
1 |
0.0071 |
| 6 |
DERMATOCHALASIS |
1 |
0.0068 |
| 7 |
CONTACT LENS INTOLERANCE |
1 |
0.0064 |
| 8 |
SKIN HYPERPIGMENTATION |
48 |
0.0056 |
| 9 |
SKIN INFLAMMATION |
1 |
0.0051 |
| 10 |
POST INFLAMMATORY PIGMENTATION CHANGE |
2 |
0.0044 |
| 11 |
GALLBLADDER CHOLESTEROLOSIS |
2 |
0.0044 |
| 12 |
INCORRECT PRODUCT STORAGE |
43 |
0.0033 |
| 13 |
ALLERGY TO VACCINE |
1 |
0.0032 |
| 14 |
TELANGIECTASIA |
3 |
0.0031 |
| 15 |
APPLICATION SITE ACNE |
1 |
0.0020 |
| 16 |
SKIN SENSITISATION |
2 |
0.0019 |
| 17 |
SKIN DISCOMFORT |
5 |
0.0019 |
| 18 |
PIGMENTATION DISORDER |
11 |
0.0018 |
| 19 |
LIFE EXPECTANCY SHORTENED |
1 |
0.0018 |
| 20 |
JUGULAR VEIN DISTENSION |
1 |
0.0018 |
| 21 |
APPLICATION SITE DISCOLOURATION |
7 |
0.0017 |
| 22 |
EYE BURNS |
1 |
0.0017 |
| 23 |
SUPERIOR VENA CAVA SYNDROME |
1 |
0.0017 |
| 24 |
SKIN FRAGILITY |
4 |
0.0016 |
| 25 |
STASIS DERMATITIS |
1 |
0.0015 |
| 26 |
INTENTIONAL UNDERDOSE |
10 |
0.0014 |
| 27 |
DARK CIRCLES UNDER EYES |
2 |
0.0014 |
| 28 |
LOCAL REACTION |
1 |
0.0013 |
| 29 |
SKIN BURNING SENSATION |
91 |
0.0013 |
| 30 |
EYELID EXFOLIATION |
1 |
0.0013 |
| 31 |
LIP ERYTHEMA |
1 |
0.0013 |
| 32 |
POOR QUALITY PRODUCT ADMINISTERED |
13 |
0.0012 |
| 33 |
APPLICATION SITE EXFOLIATION |
5 |
0.0012 |
| 34 |
SKIN INJURY |
4 |
0.0012 |
| 35 |
LIP PRURITUS |
1 |
0.0012 |
| 36 |
SKIN IRRITATION |
51 |
0.0011 |
| 37 |
PAIN OF SKIN |
29 |
0.0011 |
| 38 |
SKIN TEXTURE ABNORMAL |
1 |
0.0010 |
| 39 |
RASH PAPULAR |
21 |
0.0009 |
| 40 |
IRON OVERLOAD |
1 |
0.0009 |
| 41 |
ROSACEA |
4 |
0.0009 |
| 42 |
INCISION SITE PAIN |
1 |
0.0009 |
| 43 |
SELF ESTEEM DECREASED |
2 |
0.0008 |
| 44 |
EYELID SKIN DRYNESS |
1 |
0.0008 |
| 45 |
BLOOD IMMUNOGLOBULIN G INCREASED |
1 |
0.0008 |
| 46 |
SKIN EXFOLIATION |
69 |
0.0008 |
| 47 |
REBOUND EFFECT |
9 |
0.0008 |
| 48 |
SCAB |
9 |
0.0008 |
| 49 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
43 |
0.0008 |
| 50 |
ERYTHEMA |
161 |
0.0008 |
| 51 |
ABNORMAL SLEEP-RELATED EVENT |
1 |
0.0008 |
| 52 |
LIP EXFOLIATION |
1 |
0.0008 |
| 53 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 54 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
4 |
0.0007 |
| 55 |
DISCHARGE |
1 |
0.0007 |
| 56 |
SKIN HYPERTROPHY |
2 |
0.0007 |
| 57 |
NEOPLASM SKIN |
1 |
0.0006 |
| 58 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 59 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 60 |
DERMATITIS |
13 |
0.0006 |
| 61 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 62 |
PRODUCT COLOUR ISSUE |
3 |
0.0006 |
| 63 |
HAIR GROWTH ABNORMAL |
4 |
0.0006 |
| 64 |
SKIN SWELLING |
5 |
0.0006 |
| 65 |
INTENTIONAL PRODUCT USE ISSUE |
50 |
0.0006 |
| 66 |
INTENTIONAL PRODUCT MISUSE |
48 |
0.0005 |
| 67 |
LIP DISORDER |
1 |
0.0005 |
| 68 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 69 |
SKIN WARM |
3 |
0.0005 |
| 70 |
EARLY SATIETY |
1 |
0.0005 |
| 71 |
GALLBLADDER INJURY |
1 |
0.0005 |
| 72 |
APPLICATION SITE ERYTHEMA |
13 |
0.0005 |
| 73 |
EAR HAEMORRHAGE |
1 |
0.0005 |
| 74 |
SKIN INDURATION |
1 |
0.0005 |
| 75 |
GASTRIC BYPASS |
1 |
0.0005 |
| 76 |
SKIN DISCOLOURATION |
21 |
0.0005 |
| 77 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 78 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
31 |
0.0004 |
| 79 |
PAPULE |
3 |
0.0004 |
| 80 |
MEDICATION RESIDUE PRESENT |
2 |
0.0004 |
| 81 |
DERMATITIS ALLERGIC |
5 |
0.0004 |
| 82 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 83 |
DRY SKIN |
52 |
0.0004 |
| 84 |
MEDICATION RESIDUE |
1 |
0.0004 |
| 85 |
HERNIA REPAIR |
1 |
0.0004 |
| 86 |
SKIN WRINKLING |
1 |
0.0004 |
| 87 |
HYPERAESTHESIA |
3 |
0.0004 |
| 88 |
PLEURITIC PAIN |
1 |
0.0004 |
| 89 |
INCORRECT DRUG ADMINISTRATION DURATION |
10 |
0.0004 |
| 90 |
DERMATITIS CONTACT |
4 |
0.0004 |
| 91 |
SCAR |
6 |
0.0004 |
| 92 |
VISUAL DISTURBANCE |
2 |
0.0003 |
| 93 |
LIP PAIN |
1 |
0.0003 |
| 94 |
STRABISMUS |
1 |
0.0003 |
| 95 |
NEPHROGENIC SYSTEMIC FIBROSIS |
1 |
0.0003 |
| 96 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 97 |
KERATITIS |
1 |
0.0003 |
| 98 |
FIBROSIS |
1 |
0.0003 |
| 99 |
EYELIDS PRURITUS |
1 |
0.0003 |
| 100 |
RASH MACULAR |
11 |
0.0003 |
| 101 |
CHOLECYSTITIS CHRONIC |
2 |
0.0003 |
| 102 |
PRODUCT USE ISSUE |
54 |
0.0003 |
| 103 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 104 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 105 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
8 |
0.0003 |
| 106 |
SEBORRHOEA |
1 |
0.0003 |
| 107 |
SUNBURN |
2 |
0.0003 |
| 108 |
PRODUCT STORAGE ISSUE |
1 |
0.0003 |
| 109 |
SKIN FISSURES |
5 |
0.0003 |
| 110 |
WOUND SECRETION |
1 |
0.0003 |
| 111 |
VENOUS THROMBOSIS |
1 |
0.0003 |
| 112 |
SELF-MEDICATION |
1 |
0.0002 |
| 113 |
DRUG EFFECT DECREASED |
13 |
0.0002 |
| 114 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 115 |
CONDITION AGGRAVATED |
73 |
0.0002 |
| 116 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 117 |
ADVERSE REACTION |
3 |
0.0002 |
| 118 |
PRODUCT STORAGE ERROR |
19 |
0.0002 |
| 119 |
DEFORMITY |
2 |
0.0002 |
| 120 |
BLISTER |
12 |
0.0002 |
| 121 |
SKIN ABRASION |
1 |
0.0002 |
| 122 |
SARCOIDOSIS |
1 |
0.0002 |
| 123 |
EXPIRED DRUG ADMINISTERED |
1 |
0.0002 |
| 124 |
INJECTION SITE INFLAMMATION |
1 |
0.0002 |
| 125 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 126 |
STOMACH DISCOMFORT |
1 |
0.0002 |
| 127 |
SKIN NECROSIS |
1 |
0.0002 |
| 128 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0002 |
| 129 |
RASH ERYTHEMATOUS |
9 |
0.0002 |
| 130 |
CHEILITIS |
1 |
0.0002 |
| 131 |
CHOKING SENSATION |
1 |
0.0002 |
| 132 |
SKIN ATROPHY |
1 |
0.0002 |
| 133 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 134 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 135 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 136 |
PRODUCT USE IN UNAPPROVED INDICATION |
39 |
0.0002 |
| 137 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 138 |
SWELLING FACE |
10 |
0.0002 |
| 139 |
TENDON DISORDER |
1 |
0.0002 |
| 140 |
INTENTIONAL OVERDOSE |
9 |
0.0001 |
| 141 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 142 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
3 |
0.0001 |
| 143 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 144 |
SENSITIVE SKIN |
1 |
0.0001 |
| 145 |
EYE SWELLING |
5 |
0.0001 |
| 146 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 147 |
PRURITUS |
51 |
0.0001 |
| 148 |
PAROSMIA |
1 |
0.0001 |
| 149 |
APPLICATION SITE PRURITUS |
3 |
0.0001 |
| 150 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 151 |
STENT PLACEMENT |
1 |
0.0001 |
| 152 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 153 |
SKIN DISORDER |
4 |
0.0001 |
| 154 |
EYE PRURITUS |
4 |
0.0001 |
| 155 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 156 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 157 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 158 |
THERAPEUTIC RESPONSE UNEXPECTED |
5 |
0.0001 |
| 159 |
LIP DRY |
1 |
0.0001 |
| 160 |
OPTIC NEURITIS |
1 |
0.0001 |
| 161 |
ACNE |
8 |
0.0001 |
| 162 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 163 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 164 |
TOOTH ABSCESS |
1 |
0.0001 |
| 165 |
EAR DISCOMFORT |
1 |
0.0001 |
| 166 |
TRANSFUSION |
1 |
0.0001 |
| 167 |
SCRATCH |
1 |
0.0001 |
| 168 |
DRUG INEFFECTIVE |
123 |
0.0001 |
| 169 |
HYPERSENSITIVITY |
17 |
0.0001 |
| 170 |
RASH |
38 |
0.0001 |
| 171 |
CHOLECYSTITIS |
1 |
0.0001 |
| 172 |
THYROID CANCER |
1 |
0.0001 |
| 173 |
PARAESTHESIA |
13 |
0.0001 |
| 174 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 175 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 176 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 177 |
SKIN ULCER |
2 |
0.0001 |
| 178 |
NODULE |
1 |
0.0001 |
| 179 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 180 |
EMOTIONAL DISTRESS |
9 |
0.0001 |
| 181 |
RASH PRURITIC |
4 |
0.0001 |
| 182 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 183 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 184 |
SKIN REACTION |
1 |
0.0001 |
| 185 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 186 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
12 |
0.0001 |
| 187 |
FEELING HOT |
4 |
0.0001 |
| 188 |
ANKLE FRACTURE |
1 |
0.0001 |
| 189 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 190 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 191 |
BACK DISORDER |
1 |
0.0001 |
| 192 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 193 |
DRY EYE |
3 |
0.0001 |
| 194 |
LIP SWELLING |
2 |
0.0001 |
| 195 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 196 |
LOCAL SWELLING |
1 |
0.0001 |
| 197 |
AMENORRHOEA |
1 |
0.0001 |
| 198 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 199 |
SLEEP DISORDER |
4 |
0.0001 |
| 200 |
DRUG ERUPTION |
1 |
0.0001 |
| 201 |
UNDERDOSE |
4 |
0.0001 |
| 202 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 203 |
PHOTOPHOBIA |
1 |
0.0001 |
| 204 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 205 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 206 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 207 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 208 |
OVERDOSE |
10 |
0.0000 |
| 209 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 210 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 211 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 212 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 213 |
BURNING SENSATION |
3 |
0.0000 |
| 214 |
INJURY |
3 |
0.0000 |
| 215 |
AGEUSIA |
1 |
0.0000 |
| 216 |
ANHEDONIA |
1 |
0.0000 |
| 217 |
DEPRESSED MOOD |
2 |
0.0000 |
| 218 |
LIMB INJURY |
1 |
0.0000 |
| 219 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 220 |
SKIN LESION |
1 |
0.0000 |
| 221 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 222 |
DIVERTICULITIS |
1 |
0.0000 |
| 223 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 224 |
EYE IRRITATION |
2 |
0.0000 |
| 225 |
ASCITES |
1 |
0.0000 |
| 226 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 227 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 228 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 229 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 230 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 231 |
NIGHT SWEATS |
1 |
0.0000 |
| 232 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 233 |
FUNGAL INFECTION |
1 |
0.0000 |
| 234 |
URTICARIA |
5 |
0.0000 |
| 235 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 236 |
NIGHTMARE |
1 |
0.0000 |
| 237 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 238 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 239 |
CRYING |
1 |
0.0000 |
| 240 |
HOT FLUSH |
2 |
0.0000 |
| 241 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 242 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 243 |
JOINT SWELLING |
3 |
0.0000 |
| 244 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 245 |
THROAT IRRITATION |
1 |
0.0000 |
| 246 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 247 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 248 |
SWELLING |
2 |
0.0000 |
| 249 |
ANXIETY |
6 |
0.0000 |
| 250 |
FLUSHING |
2 |
0.0000 |
| 251 |
FLUID RETENTION |
1 |
0.0000 |
| 252 |
NERVOUSNESS |
1 |
0.0000 |
| 253 |
ECZEMA |
1 |
0.0000 |
| 254 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 255 |
OFF LABEL USE |
16 |
0.0000 |
| 256 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 257 |
NECK PAIN |
1 |
0.0000 |
| 258 |
EYE PAIN |
1 |
0.0000 |
| 259 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 260 |
CATARACT |
1 |
0.0000 |
| 261 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 262 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 263 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 264 |
VERTIGO |
1 |
0.0000 |
| 265 |
DISCOMFORT |
1 |
0.0000 |
| 266 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 267 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 268 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 269 |
FALL |
5 |
0.0000 |
| 270 |
MOBILITY DECREASED |
1 |
0.0000 |
| 271 |
EPISTAXIS |
1 |
0.0000 |
| 272 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 273 |
DRY MOUTH |
1 |
0.0000 |
| 274 |
DIZZINESS |
6 |
0.0000 |
| 275 |
PAIN |
7 |
0.0000 |
| 276 |
HEADACHE |
7 |
0.0000 |
| 277 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 278 |
DYSPHAGIA |
1 |
0.0000 |
| 279 |
MIGRAINE |
1 |
0.0000 |
| 280 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 281 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 282 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 283 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 284 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 285 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 286 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 287 |
CONSTIPATION |
2 |
0.0000 |
| 288 |
DEPRESSION |
2 |
0.0000 |
| 289 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 290 |
PALPITATIONS |
1 |
0.0000 |
| 291 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 292 |
FEELING ABNORMAL |
2 |
0.0000 |
| 293 |
HYPERHIDROSIS |
1 |
0.0000 |
| 294 |
PSORIASIS |
1 |
0.0000 |
| 295 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 296 |
TREMOR |
1 |
0.0000 |
| 297 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 298 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 299 |
MYALGIA |
1 |
0.0000 |
| 300 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 301 |
MUSCLE SPASMS |
1 |
0.0000 |
| 302 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 303 |
DYSPNOEA |
3 |
0.0000 |
| 304 |
ANAEMIA |
1 |
0.0000 |
| 305 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 306 |
ALOPECIA |
1 |
0.0000 |
| 307 |
NAUSEA |
4 |
0.0000 |
| 308 |
SOMNOLENCE |
1 |
0.0000 |
| 309 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 310 |
HYPERTENSION |
1 |
0.0000 |
| 311 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 312 |
DECREASED APPETITE |
1 |
0.0000 |
| 313 |
FATIGUE |
3 |
0.0000 |
| 314 |
INSOMNIA |
1 |
0.0000 |
| 315 |
WEIGHT DECREASED |
1 |
0.0000 |
| 316 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 317 |
DIARRHOEA |
2 |
0.0000 |
| 318 |
PYREXIA |
1 |
0.0000 |
| 319 |
ARTHRALGIA |
1 |
0.0000 |
| 320 |
MALAISE |
1 |
0.0000 |
| 321 |
VOMITING |
1 |
0.0000 |